EIF3A
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
eukaryotic translation initiation factor 3 subunit A | MIM:602039 | Ensembl:ENSG00000107581 | HGNC:HGNC:3271 | PA27699 | 10q26.11 |
GO terms in EIF3A
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IBA | GO:0001732 | formation of cytoplasmic translation initiation complex |
BP | IDA | GO:0001732 | formation of cytoplasmic translation initiation complex |
BP | IBA | GO:0002188 | translation reinitiation |
BP | IC | GO:0006413 | translational initiation |
BP | TAS | GO:0006413 | translational initiation |
BP | IEA | GO:0070373 | negative regulation of ERK1 and ERK2 cascade |
BP | IDA | GO:0075522 | IRES-dependent viral translational initiation |
BP | IDA | GO:0075525 | viral translational termination-reinitiation |
CC | IDA | GO:0005634 | nucleus |
CC | IDA | GO:0005730 | nucleolus |
CC | NAS | GO:0005737 | cytoplasm |
CC | IDA | GO:0005829 | cytosol |
CC | TAS | GO:0005829 | cytosol |
CC | IDA | GO:0005852 | eukaryotic translation initiation factor 3 complex |
CC | IEA | GO:0005874 | microtubule |
CC | HDA | GO:0016020 | membrane |
CC | IBA | GO:0043614 | multi-eIF complex |
CC | IBA | GO:0071540 | eukaryotic translation initiation factor 3 complex, eIF3e |
CC | IBA | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m |
MF | HDA | GO:0003723 | RNA binding |
MF | IDA | GO:0003723 | RNA binding |
MF | IBA | GO:0003729 | mRNA binding |
MF | IBA | GO:0003743 | translation initiation factor activity |
MF | IC | GO:0003743 | translation initiation factor activity |
MF | IDA | GO:0003743 | translation initiation factor activity |
MF | NAS | GO:0005198 | structural molecule activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0030971 | receptor tyrosine kinase binding |
Gene expression in normal tissue: EIF3A
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in EIF3A
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP107 | Translation Factors |
kegg | hsa03013 | RNA transport - Homo sapiens (human) |
pid | il2_pi3kpathway | IL2 signaling events mediated by PI3K |
biocarta | eifpathway | eukaryotic protein translation |
biocarta | irespathway | internal ribosome entry pathway |
biocarta | mtorpathway | mtor signaling pathway |
reactome | R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression |
reactome | R-HSA-392499 | Metabolism of proteins |
reactome | R-HSA-72613 | Eukaryotic Translation Initiation |
reactome | R-HSA-72649 | Translation initiation complex formation |
reactome | R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
reactome | R-HSA-72689 | Formation of a pool of free 40S subunits |
reactome | R-HSA-72695 | Formation of the ternary complex, and subsequently, the 43S complex |
reactome | R-HSA-72702 | Ribosomal scanning and start codon recognition |
reactome | R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit |
reactome | R-HSA-72737 | Cap-dependent Translation Initiation |
reactome | R-HSA-72766 | Translation |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD286 | Nsc 632839 | 5 |
iGMDRD562 | Navitoclax | 3 |
iGMDRD552 | AZD-1775 | 3 |
iGMDRD263 | AACOCF3 | 3 |
iGMDRD246 | NPC26 | 5 |
iGMDRD524 | ISX-9 | 3 |
iGMDRD202 | Curcumin | 9 |
iGMDRD138 | PX 12 | 3 |
iGMDRD5 | Tyrphostin AG 1478 | 3 |
iGMDRD289 | Parthenolide | 3 |
iGMDRD434 | BMS-536924 | 3 |
iGMDRD52 | Rotenone | 1 |
iGMDRD446 | LY 2183240 | 1 |
iGMDRD639 | YK 4-279 | 3 |
iGMDRD698 | Neratinib | 3 |
iGMDRD193 | Fqi1 | 3 |
iGMDRD211 | (1S,3R)-RSL3 | 3 |
iGMDRD123 | Isoevodiamine | 6 |
iGMDRD394 | BX-795 | 1 |
iGMDRD435 | BI-2536 | 3 |
iGMDRD486 | Tosedostat | 3 |
iGMDRD584 | VER 155008 | 2 |
iGMDRD670 | ML 210 | 5 |
iGMDRD494 | Neopeltolide | 2 |
iGMDRD462 | OSI-906 (Linsitinib) | 1 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in EIF3A